Relative Strength Chart Amarin Corporation plc
Stocks
AMRN
US0231114044
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 12.74 USD | -0.08% |
|
+9.78% | -8.74% |
| 10-28 | Amarin Corporation plc, Q3 2026 Earnings Call, Oct 28, 2026 | |
| 10-28 | Amarin Corporation plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMARIN CORPORATION PLC | Bio Therapeutic Drugs | -0.08% | +9.78% | -8.74% | -24.24% | -86.65% | 269M |  |  | |
- Stock Market
- Stocks
- AMRN Stock
- Charts Amarin Corporation plc
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
